MARKET ACCESS IS ENTERING ITS COLLABORATIVE ERA

By Casey McCann, President

Just back from Asembia's AXS26 Summit, one message came through clearly across conversations with payers, manufacturers, and solution partners alike: market access is evolving into a far more collaborative discipline.

This shift is not incremental. It reflects a broader rethinking of how access is designed, communicated, and sustained in an increasingly complex healthcare ecosystem. Three themes stood out most.

Market Access as a Design Principle, Not a Milestone

Access is no longer something to “solve” after clinical readout or regulatory approval. It is being treated as a foundational design principle, embedded far earlier in the lifecycle.

 From pipeline strategy to launch planning, access considerations are moving upstream. Commercial success increasingly depends on aligning clinical strategy, evidence generation, and payer expectations from the very beginning. Retrofitting access narratives late in the process is giving way to integrated planning that anticipates evidentiary and economic questions before they are asked.

More Data, Higher Expectations for Clarity

Healthcare has no shortage of data. What is missing is not volume but meaning.

At Asembia, the most productive discussions focused on interpretation rather than accumulation. Payers are looking for clear, decision-ready narratives that connect clinical nuance, real-world evidence, and economic impact in a way that supports confident action.

The bar for clarity has risen. Success now hinges on the ability to translate complex data sets into insights that are not only credible, but also relevant and usable within real-world access decisions.

From Positioning to Partnership

Perhaps the strongest signal was a cultural one. Market access is becoming less about positioning and more about partnership.

Payers, manufacturers, and solution partners are increasingly engaging in shared problem-solving across some of the industry’s most consequential challenges, including affordability, sustainability, and patient access. The emphasis is shifting toward collaboration that recognizes mutual constraints and collective responsibility.

This mindset change is reshaping how value is defined and delivered across the access ecosystem.

Asembia has long reflected where market access stands and often where it is headed next. This year’s message was unmistakable: the future belongs to organizations that can turn complexity into clarity, early and together.

Previous
Previous

AI‑ENABLED HUMAN REPRESENTATION IN PHARMACEUTICAL MARKETING 

Next
Next

DESIGNING AI THAT HOLDS UP: KEY TAKEAWAYS FROM INTELLUS WORLDWIDE 2026